ATG5 and Alzheimer disease: BACE1-AS is upregulated in serum samples of AD patients and brain tissues of AD transgenic (Tg) mice [58], promoting neuronal damage mediated by autophagy by binding to miR-214-3p and indirectly inhibiting ATG5 expression [58].